These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6333273

  • 1. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P, Leidig S, Heckl-Oestreicher B.
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [Abstract] [Full Text] [Related]

  • 2. Somatic H-2Kk variants reveal nonidentity of serological and cytotoxic T cell-defined Kk determinants.
    Vohr HW, Holtkamp B, Rajewsky K.
    Eur J Immunol; 1983 Oct; 13(10):846-51. PubMed ID: 6196205
    [Abstract] [Full Text] [Related]

  • 3. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR.
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [Abstract] [Full Text] [Related]

  • 4. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B, Tite JP, Janeway CA.
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [Abstract] [Full Text] [Related]

  • 5. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR.
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [Abstract] [Full Text] [Related]

  • 6. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 7. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [Abstract] [Full Text] [Related]

  • 8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ, Wheelock EF.
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [Abstract] [Full Text] [Related]

  • 9. Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.
    Ohlén C, Bastin J, Ljunggren HG, Foster L, Wolpert E, Klein G, Townsend AR, Kärre K.
    J Immunol; 1990 Jul 01; 145(1):52-8. PubMed ID: 2358681
    [Abstract] [Full Text] [Related]

  • 10. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R, Graziano RF, Green WR.
    J Immunol; 1986 Mar 15; 136(6):2271-9. PubMed ID: 3005407
    [Abstract] [Full Text] [Related]

  • 11. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.
    Altevogt P, Kurnick JT, Kimura AK, Bosslet K, Schirrmacher V.
    Eur J Immunol; 1982 Apr 15; 12(4):300-7. PubMed ID: 6124426
    [Abstract] [Full Text] [Related]

  • 12. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA, Mayordomo JI, DeLeo RM, Storkus WJ, Lotze MT, DeLeo AB.
    Cancer Res; 1995 Jan 01; 55(1):124-8. PubMed ID: 7528638
    [Abstract] [Full Text] [Related]

  • 13. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N, Fontaine P, Perreault C.
    Transplantation; 1994 Jul 15; 58(1):59-67. PubMed ID: 8036709
    [Abstract] [Full Text] [Related]

  • 14. Differential lack of class I H-2d antigen expression by sublines of the BALB/c S49 T cell lymphoma.
    Joseph LJ, Levy E, Ozato K, Hochman J, Shearer GM.
    J Immunol; 1986 Dec 15; 137(12):4016-20. PubMed ID: 3491154
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic T cell lysis of H-2-negative murine sarcoma cells.
    Noll G, Schmidt W, Bauer H.
    Eur J Immunol; 1986 May 15; 16(5):531-6. PubMed ID: 3486129
    [Abstract] [Full Text] [Related]

  • 16. Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agents.
    Altevogt P, von Hoegen P, Schirrmacher V.
    Int J Cancer; 1986 Nov 15; 38(5):707-11. PubMed ID: 3490445
    [Abstract] [Full Text] [Related]

  • 17. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.
    Schirrmacher V, Landolfo S, Zawatzky R, Kirchner H.
    Invasion Metastasis; 1981 Nov 15; 1(3):175-94. PubMed ID: 6821364
    [Abstract] [Full Text] [Related]

  • 18. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells.
    Stroynowski I, Clark S, Henderson LA, Hood L, McMillan M, Forman J.
    J Immunol; 1985 Sep 15; 135(3):2160-6. PubMed ID: 2410513
    [Abstract] [Full Text] [Related]

  • 19. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V.
    Invasion Metastasis; 1981 Sep 15; 1(1):4-21. PubMed ID: 7188381
    [Abstract] [Full Text] [Related]

  • 20. Intradomain H-2Kd/Dd recombinants define the same regions as crucial for recognition by alloreactive or major histocompatibility complex-restricted cytolytic T cells.
    Maryanski JL, Abastado JP, MacDonald HR, Kourilsky P.
    Eur J Immunol; 1989 Jan 15; 19(1):193-6. PubMed ID: 2465901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.